deferoxamine and amg531

deferoxamine has been researched along with amg531 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Leitch, HA; Vickars, LM1
Bastian, TW; Chen, MJ; Connor, JR; Duck, KA; Georgieff, MK; Lanier, LM; Liu, ZJ; Michalopoulos, GC; Sola-Visner, MC1
Chen, YL; Cooper, N; Garbowski, M; Hider, R; Koonyosying, P; Porter, J; Psaila, B; Sola-Visner, M; Vlachodimitropoulou, E1

Reviews

1 review(s) available for deferoxamine and amg531

ArticleYear
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Aged; Anemia; Benzoates; Blood Component Transfusion; Chelation Therapy; Combined Modality Therapy; Deferoxamine; Hematopoietic Cell Growth Factors; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Overload; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Off-Label Use; Phlebotomy; Practice Guidelines as Topic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin

2009

Other Studies

3 other study(ies) available for deferoxamine and amg531

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development.
    Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:3

    Topics: Anemia, Iron-Deficiency; Animals; Benzoates; Biological Transport; Biomimetics; Blood-Brain Barrier; Cattle; Chelating Agents; Deferoxamine; Dendrites; Green Fluorescent Proteins; Hippocampus; Hydrazines; Iron; Mice; Microcirculation; Neuroglia; Neurons; Pyrazoles; Thrombocytopenia; Thrombopoietin

2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
    Blood, 2017, 10-26, Volume: 130, Issue:17

    Topics: Animals; Benzoates; Cell Line, Tumor; Deferoxamine; Extracellular Space; Ferritins; Hepatocytes; Humans; Hydrazines; Insulin; Insulin Secretion; Insulin-Secreting Cells; Iron; Iron Chelating Agents; Myocytes, Cardiac; Pyrazoles; Pyridones; Rats; Reactive Oxygen Species

2017